Abstract

Initiation of rapid antiretroviral therapy (ART) for newly diagnosed HIV-infected individuals is recommended to reduce mortality and morbidity and to prevent transmission to others. It is emphasized that the treatment should be started as early as possible, as it increases the probability of receiving the treatment and being under treatment, decreases the time required to achieve viral suppression and increases viral suppression rates. However, the health institution’s infrastructure, the clinical-social status of the patient and the quality of the treatment to be initiated should be appropriate for rapid ART.